- Home
- TTD vs BNTX Comparison
TTD vs BNTX Comparison
Compare TTD & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTD
- BNTX
- Stock Information
- Founded
- TTD 2009
- BNTX 2008
- Country
- TTD United States
- BNTX Germany
- Employees
- TTD N/A
- BNTX N/A
- Industry
- TTD Computer Software: Programming Data Processing
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TTD Technology
- BNTX Health Care
- Exchange
- TTD Nasdaq
- BNTX Nasdaq
- Market Cap
- TTD 23.4B
- BNTX 25.0B
- IPO Year
- TTD 2016
- BNTX 2019
- Fundamental
- Price
- TTD $71.04
- BNTX $92.77
- Analyst Decision
- TTD Buy
- BNTX Strong Buy
- Analyst Count
- TTD 34
- BNTX 17
- Target Price
- TTD $104.06
- BNTX $145.17
- AVG Volume (30 Days)
- TTD 11.0M
- BNTX 1.5M
- Earning Date
- TTD 05-08-2025
- BNTX 05-05-2025
- Dividend Yield
- TTD N/A
- BNTX N/A
- EPS Growth
- TTD 104.63
- BNTX N/A
- EPS
- TTD 0.82
- BNTX N/A
- Revenue
- TTD $2,569,599,000.00
- BNTX $2,968,331,171.00
- Revenue This Year
- TTD $18.49
- BNTX N/A
- Revenue Next Year
- TTD $19.50
- BNTX $10.02
- P/E Ratio
- TTD $86.79
- BNTX N/A
- Revenue Growth
- TTD 25.07
- BNTX 0.61
- 52 Week Low
- TTD $42.96
- BNTX $76.53
- 52 Week High
- TTD $141.53
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- TTD 74.74
- BNTX 41.85
- Support Level
- TTD $53.35
- BNTX $92.26
- Resistance Level
- TTD $56.84
- BNTX $106.99
- Average True Range (ATR)
- TTD 2.57
- BNTX 6.52
- MACD
- TTD 2.16
- BNTX -1.37
- Stochastic Oscillator
- TTD 83.16
- BNTX 1.80
About TTD The Trade Desk Inc.
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. It uses data in an iterative manner to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.